8 Results for "

Antiplatelet agent1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Antiplatelet agent1" in MCE Product Catalog:

Cat. No.: HY-146498
CAS No.: 2493297-12-2
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease Cancer

Antiplatelet agent 1 (compound 7q) is a Ticagrelor analoguehas, possessing antiplatelet activity. Antiplatelet agent 1 can be used for researching platelet aggregation .
loading...
    loading...
Cat. No.: HY-N1723
CAS No.: 191547-12-3
2-Deacetoxytaxinine B is a potent antiplatelet agent .
loading...
    loading...
Cat. No.: HY-119410
CAS No.: 120824-08-0
Synonyms: HN11500
Research Areas:  

Cardiovascular Disease

Linotroban (HN11500), a Sulotroban (HY-158332) derivative, is an orally active, potent non-prostanoid thromboxane receptor antagonist (TXRA) with a strong antiplatelet profile. Linotroban is used as antithrombotic agent .
loading...
    loading...
Cat. No.: HY-106080A
CAS No.: 85666-17-7
Purity:  99.82%
Synonyms: U-63557A
Research Areas:  

Cardiovascular Disease

Furegrelate Sodium (U-63557A) is a potent, orally available, and selective thromboxane synthase inhibitor. Furegrelate Sodium inhibits human platelet microsomal thromboxane A2 (TxA2) synthase with an IC50 of 15 nM. Furegrelate Sodium is being developed as an antiplatelet agent .
loading...
    loading...
Cat. No.: HY-106080
CAS No.: 85666-24-6
Synonyms: U-63557A free acid
Research Areas:  

Cardiovascular Disease

Furegrelate (U-63557A free acid) is a potent, orally available, and selective thromboxane synthase inhibitor. Furegrelate inhibits human platelet microsomal thromboxane A2 (TxA2) synthase with an IC50 of 15 nM. Furegrelate is being developed as an antiplatelet agent .
loading...
    loading...
Cat. No.: HY-106080AR
CAS No.: 85666-17-7
Synonyms: U-63557A (Standard)
Furegrelate (sodium) (Standard) is the analytical standard of Furegrelate (sodium). This product is intended for research and analytical applications. Furegrelate Sodium (U-63557A) is a potent, orally available, and selective thromboxane synthase inhibitor. Furegrelate Sodium inhibits human platelet microsomal thromboxane A2 (TxA2) synthase with an IC50 of 15 nM. Furegrelate Sodium is being developed as an antiplatelet agent .
loading...
    loading...
Cat. No.: HY-115911
CAS No.: 880399-00-8
Target:  

Glycoprotein VI

Research Areas:  

Cardiovascular Disease

GPVI antagonist 2 (Compound 1) is a potential antagonist of Glycoprotein VI (GPVI). IC50 values of GPVI antagonist 2 are, respectively, 0.35 μM for collagen, 0.80 μM for CRP, 195.2 μM for convulxin and 81.38 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 2 is a promising antiplatelet agent .
loading...
    loading...
Cat. No.: HY-115912
CAS No.: 901654-94-2
Target:  

Glycoprotein VI

Research Areas:  

Cardiovascular Disease

GPVI antagonist 3 (Compound 2) is a potential antagonist of Glycoprotein VI (GPVI). IC50 values of GPVI antagonist 3 are, respectively, 1.01 μM for collagen, 1.92 μM for CRP, 7.24 μM for convulxin and 51.74 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 3 is a promising antiplatelet agent .
loading...
    loading...